How groundbreaking is Amazon's RxPass?

The latest stories trending on MedCity News.

Editor's Pick

Top Story Is Amazon's RxPass Breaking New Ground in Creating Access to Affordable Drugs? Amazon's RxPass offers more than 50 generic drugs for more than 80 common conditions at the flat fee of $5 a month for Prime members. While one expert says its a significant move by Amazon, another said more needs to be done. Do You Want $20K in Advertising for Your Startup? Application Deadline is January 30th   There is no fee to apply. Only companies funded from 2018-2022 (no more than five years ago), and that have raised a seed funding round will be considered. Startups can apply to only one track. Startups must be registered for the conference in order to participate in the pitch contest. There are five tracks and each track will feature six finalists. Application Deadline: January 30, 2023. Applications will be reviewed by investment professionals and selections announced on Feb. 21, 2023.   Apply Now

Featured News

Healthcare Hires of Note Check out executive hires from SnapNurse, Almaden Genomics, Dr. Evidence, Healthy.io, Wheel, and Sage Bionetworks. Astellas Plots Near-Term Moves to Execute Long-Term Vision in Gene Therapy Astellas has become an active player in gene therapy. MedCity News caught up with company executive Richard Wilson, who explained Astellas's strategy, the clinical holds on its two most advanced programs, and the rationale behind its recent gene therapy deals. Report: Wisdo Reduces Loneliness Among Humana MA Members Wisdo, a social health platform that addresses loneliness and social isolation, teamed up with Humana to serve some of its Medicare Advantage members. A new study on Humana's members found that 58% of participants reported lower rates of loneliness after three months of using Wisdo's app. Q4 Was Digital Health's Worst Quarter for Funding in 5 Years Digital health's investment slowdown is so severe that the fourth quarter of 2022 marked the lowest quarterly digital health funding total in the past five years, according to new report. Q4 was also the first quarter with no new unicorn births since 2018. Gut Punch: Finch's Flagging Microbiome Program Folds, Leading to 95% Staff Cut Clinical trial setbacks and financial challenges have led Finch Therapeutics to stop a Phase 3 study for its lead microbiome program, a potential treatment for recurrent C. diff infection. As Finch seeks buyers for its remaining assets, the biotech is laying off most of its staff in a corporate restructuring. Alleviating Healthcare's Most Pressing Crisis: Labor Shortages Solving the labor shortage in healthcare requires that organizations come together and try new strategies leveraging their own data to better understand what their teams need. What To Look For In A HIPAA-Compliant Vendor By following a checklist of considerations to ensure vendors are up to par with regulations and industry standards, you will be protected against any potential future liabilities and ensure that your Personal Health Information is protected. Top 5 FDA considerations for medtech-enabled data platforms Medtech companies should have a team of FDA advisors at the ready to develop and implement pre- and post-market strategies, prevent and resolve pre- or post-market issues and guide lifecycle management

Resources

Healthcare Contract Management Software – A CLM Introduction In this whitepaper, you will learn how contract management software is helping healthcare providers, hospitals, mental health facilities, and other healthcare organizations mitigate risk, increase compliance, and drive process and operational efficiencies. It outlines the business drivers and benefits that the healthcare industry can and is realizing from adopting contract management software.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe